AzTrials
AzTrials

Situational Erectile DysfunctionPRIMEDNCT04341025

Providing Insight Into and Mindfulness for Situational Erectile Dysfunction

A study testing Mindfulness based psychosexual therapy ( MBPST) in people with Situational Erectile Dysfunction, run by Vancouver Coastal Health at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Erectile dysfunction (ED) is among the most common sexual dysfunctions experienced by men, affecting at least one third of men across the lifespan. Although pharmacological treatments are available, adherence to these treatments is poor, suggesting the need for integration of psychological interventions. Read more about this study

Who is it for?
Ages 19 years and older, men only
Conditions the study is for
Situational Erectile Dysfunction
What is being tested?
Mindfulness based psychosexual therapy ( MBPST)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteCanada
Study dates
14 Apr 2020to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • This study is open to individuals who are:
  • Diagnosed with situational erectile dysfunction (ED) of at least 6 months duration, as assessed by a physician at the BC Centre for Sexual Medicine according to DSM-5 criteria
  • 19 years of age or older
  • Fluent enough in English to participate in group
  • Willing to abstain from using medications for ED (i.e., PDE5 inhibitors, intracavernosal injections, MUSE etc.) from the start of treatment until the 1-month follow-up (totaling 10 weeks)
  • Comfortable and interested in participating in a small group format with 6-10 others

Who cannot join

  • This study is not suitable for individuals who:
  • Do not experience an exacerbation of ED in the partnered context
  • Have a current unmanaged health condition (e.g., unmanaged diabetes mellitus) or unstable mental health condition (e.g., severe depression/anxiety, active suicidal ideation) that would interfere with self- or partnered-sexual activities or with group participation
  • Do no feel comfortable participating in a small group format with 6-10 others

Trial locations and contacts

1 site in 1 country.

Shauna Correia, MD contact

604-875-4705

shauna.correia@vch.ca

Miriam Driscoll, MD contact

604-875-4705

miriam.driscoll@vch.ca

Canada1 site, 1 recruiting
  • Vancouver General Hospital

    Vancouver, British Columbia, V5Z 1M9

    Miriam Driscoll, MD

    Recruiting

Other trials in Canada

About this study

Erectile dysfunction (ED) is among the most common sexual dysfunctions experienced by men, affecting at least one third of men across the lifespan. Although pharmacological treatments are available, adherence to these treatments is poor, suggesting the need for integration of psychological interventions. This study will determine if a 6-session mindfulness-based psychosexual therapy (MBPST) group will be effective and feasible for men with situational ED. This study is adapted from a previously published 4-session MBPST protocol which was found to be beneficial for men with situational ED. Outcomes are measured using self-report questionnaires on sexual functioning/enjoyment, relationship satisfaction, and treatment acceptability.

Read the detailed description

PURPOSE The purpose of this study is to assess the feasibility and efficacy of a 6-session mindfulness-based psychosexual therapy (MBPST) treatment protocol using self-report questionnaires. The current protocol is adapted from a pre-existing 4-session mindfulness-based psychosexual therapy (MBPST) protocol from a pilot study which has already demonstrated benefits in the treatment of situational erectile dysfunction (ED). The six sessions include elements of psychoeducation, cognitive therapy, mindfulness training, and sex therapy techniques. The elements comprising the six sessions are evidence-based, as their effectiveness has been demonstrated in female samples (e.g., Brotto et al., 2012; Paterson et al., 2017), and more recently in the context of a four-session pilot in men with situational ED (H15-03172; published in Bossio et al., 2018). The rationale for an increase from a 4 to 6-session approach came from qualitative analysis of participant perspectives in the pilot study and from investigator experience.

HYPOTHESES

  1. Men who undergo MBPST treatment will show significant post-treatment improvements at follow-up (immediately following treatment and at 1- and 4-months after treatment completion), compared to baseline, to primary endpoints of: (i) erectile functioning; (ii) sexual distress; (iii) sexual satisfaction and pleasure.
  2. Men who undergo MBPST treatment will show significant post-treatment improvements at follow-up (immediately following treatment and at 1- and 4-months after treatment completion), compared to baseline, to secondary endpoints of: (i) psychological variables/mental status (i.e., anxiety); (ii) mindfulness-related variables; and (iii) relationship satisfaction. The role of secondary endpoints as mediators to primary endpoints of sexual functioning will also be assessed.
  3. Men will report significantly less use of medications for ED (i.e., PDE5 inhibitors and intracavernosal injections) at 4-month follow-up compared to pre-treatment.

JUSTIFICATION Sexual dysfunction affects at least one third of men across the lifespan (Laumann, Paik, \& Rosen, 1999), and can have significant impact on quality of life and on intimate relationships (Hatzimouratidis et al., 2010). Erectile dysfunction (ED), or the inability to attain and/or maintain an erection sufficient for satisfactory sexual activity (NIH, 1993), is among the most common sexual dysfunctions experienced by men. The aetiology of ED is complex and can result from a variety of physiological (e.g., age, cardiovascular health, medication use), psychological (e.g., anxiety), and lifestyle factors (e.g., smoking status; Nicolosi, Moreira, Shirai, Tambi, \& Glasser, 2003). Situational ED refers to ED that occurs in certain contexts (e.g., with a partner), but not others (e.g., masturbation, nocturnal erections).

Although pharmacological interventions (i.e., PDE5 inhibitors) have been available to treat ED since the 1990's, adherence to these treatments is poor, with approximately 50% of men failing to re-fill their first prescription (Carvalheira, Pereira, Maroco, \& Forjaz, 2012; Hanash, 1997), despite the restoration of erections (Giannitsas, Konstantinopoulos, Patsialas, \& Perimenis, 2008). This low adherence to pharmacological treatments suggests that there are aspects of ED, beyond the rigidity of erections that are not being addressed by medications. This may be particularly true in the case of situational ED, where psychogenic factors are playing a major role (McCabe et al., 2016).

There is increasing evidence documenting the benefits of MBCT for women with sexual dysfunction (Brotto, Basson, \& Luria, 2008; Brotto et al., 2008; Brotto et al., 2012; Brotto, Seal, \& Rellini, 2012; Brotto \& Basson, 2014; Paterson, Handy, \& Brotto, 2017). Further, the investigators recently adapted a pre-existing 4-session MBPST protocol, which had already been shown to be effective in the treatment of female sexual dysfunction, to fit the needs of men with situational ED and pilot-tested it in group format (H15-03172). Our pilot data suggest significant benefits for men with situational ED (Bossio, Basson, Driscoll, Correia, \& Brotto, 2019). However, feedback from the pilot participants indicated a need for additional sessions as they had only begun to establish a regular mindfulness practice. Mindfulness-based interventions consisting of eight sessions are common and have been shown to be effective in reducing depressive symptoms (Sipe \& Eisendrath, 2012), depressive relapse (Teasdale, Segal, Williams, Ridgeway, Soulsby, \& Lau, 2000), and anxiety (Evans, Ferrando, Findler, Stowell, Smart, \& Haglin, 2008). However, the investigators were skeptical about the willingness and ability of patients to commit to eight consecutive weeks of treatment. Therefore, the current project is a pilot study intended to assess the feasibility and efficacy of a 6-session MBPST program for situational ED.

OBJECTIVES The main objective of this study is to test the feasibility and efficacy of a 6-session MBPST protocol for men with situational ED. Specifically, the investigators hope to find that men who undergo this treatment will experience improvements in primary (e.g., decreased erectile dysfunction and sexual distress), and secondary endpoints (e.g., increased relationship satisfaction and mental well-being). Further, the investigators hope to find that gains in the primary and secondary endpoints are maintained at 1- and 4-months.

RESEARCH DESIGN Participants (N=60) will take part in a 6-session MBPST group (n=6-10) for treatment of situational ED, either in-person or in an online format. Each session will be 2 hours in length and will be spaced one week apart, for a total of 12 hours of treatment time. Participants will also take part in supportive group follow-up sessions at 1- and 4-months following group completion where participants are free to share their experiences with the group, ask questions, and participate in troubleshooting. Treatment endpoints will be assessed at four time-points (pre-treatment (Time 1), immediate post-treatment (Time 2), 1-month post-treatment (Time 3), and 4-months post-treatment (Time 4)).

STATISTICAL ANALYSIS One-way repeated-measures multivariate analysis of variance (MANOVA) will be used to assess our primary hypothesis-that men will show improvements in primary (i.e., sexual functioning) endpoints following treatment-with the primary endpoint measures as the dependent variables (e.g., ED severity, sexual distress, sexual satisfaction, pleasure), time-point (pre-treatment, immediate post-treatment, 1-month post-treatment, and 4-months post-treatment) as the independent variable, and age as a covariate.

Our secondary hypotheses-that men will show improvements secondary endpoints (i.e., mindfulness-related variables, mental status, and relationship factors) following treatment-will also be examined using the same repeated-measures MANOVA strategy described above. The hypothesis that secondary endpoints act as mediators of sexual functioning following treatment will also be examined using repeated-measures ANOVAs with primary endpoint measures as the dependent variable (i.e., sexual functioning), time-point (pre-treatment, immediate post-treatment, 1-month post-treatment, and 4-months post-treatment) as the independent variable, and secondary endpoints (e.g., change in relationship satisfaction) as mediators.

Our tertiary hypothesis-that men will report using medications for ED significantly less 4-months after treatment conclusion compared with pre-treatment use-will be assessed using paired-sample t-tests comparing frequency of use and dose before treatment and 4-months after treatment.

Being tested
Mindfulness based psychosexual therapy ( MBPST)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness based psychosexual therapy ( MBPST)Behavioural

    Also called MBCT ( Mindfulness based cognitive therapy )

    The group treatment sessions will integrate empirically supported elements of psychoeduation, cognitive behavioural therapy, and mindfulness skills. Each of the six sessions will follow the well-defined manualized treatment protocol. The treatment is adapted from the study team's previous mindfulness-based treatment group (H15-03172), for situational ED which has been shown to be effective. Participants will be provided with handouts and asked to complete approximately 10-60 minutes/day of at-home practice/skills, which may include reading material, mindfulness exercises, and/or behavioural exercises between sessions. During the 2 follow-up sessions, participants will be invited to share their experience since the conclusion of group, ask questions, and participate in troubleshooting.

Study groups in NCT04341025
Study groupRoleWhat they receive
Single ArmOtherPatients are compared to themselves before and after the treatment.
Receives: Behavioral: Mindfulness based psychosexual therapy ( MBPST)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5

    (IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire

    Measured: Change from baseline to immediately post treatment (6 weeks)

  2. Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5

    (IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire

    Measured: Change from baseline to one month post-treatment (10 weeks)

  3. Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5

    (IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire

    Measured: Change from baseline to four months post-treatment (22 weeks)

  4. Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised

    (Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale

    Measured: Change from baseline to immediately post treatment (6 weeks)

  5. Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised

    (Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale

    Measured: Change from baseline to one month post-treatment (10 weeks)

  6. Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised

    (Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale

    Measured: Change from baseline to four months post-treatment (22 weeks)

  7. Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning

    (Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale

    Measured: Change from baseline to immediately post treatment (6 weeks)

  8. Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning

    (Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale

    Measured: Change from baseline to one month post-treatment (10 weeks)

  9. Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning

    (Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale

    Measured: Change from baseline to four months post-treatment (22 weeks)

  10. Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale.

    (Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire

    Measured: Change from baseline to immediately post treatment (6 weeks)

  11. Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale

    (Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire

    Measured: Change from baseline to one month post-treatment (10 weeks)

  12. Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale

    (Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire

    Measured: Change from baseline to four months post-treatment (22 weeks)

  13. Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire

    2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.

    Measured: Change from baseline to immediately post treatment (6 weeks)

  14. Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire

    2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.

    Measured: Change from baseline to one month post-treatment (10 weeks)

  15. Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire

    2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.

    Measured: Change from baseline to four months post-treatment (22 weeks)

Secondary outcomes (12)
  1. Anxiety Symptoms as measured by Generalized Anxiety Disorder-7

    (Spitzer, Kroenke, Williams, \& Lowe, 2006),7-item questionnaire

    Measured: Change from baseline to immediately post treatment (6 weeks)

  2. Anxiety Symptoms as measured by Generalized Anxiety Disorder-7

    (Spitzer, Kroenke, Williams, \& Lowe, 2006), 7-item questionnaire

    Measured: Change from baseline to one month post-treatment (10 weeks)

  3. Anxiety Symptoms as measured by Generalized Anxiety Disorder-7

    (Spitzer, Kroenke, Williams, \& Lowe, 2006), 7-item questionnaire

    Measured: Change from baseline to four months post-treatment (22 weeks)

  4. Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15

    (Baer, Carmody, Hunsinger, 2012; Gu, Strauss, Crane, Barnhofer, Karl, Cavanagh, \& Kuyken, 2016),15-item questionnaire

    Measured: Change from baseline to immediately post treatment (6 weeks)

  5. Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15

    (Baer, Carmody, Hunsinger, 2012; Gu, Strauss, Crane, Barnhofer, Karl, Cavanagh, \& Kuyken, 2016),15-item questionnaire

    Measured: Change from baseline to one month post-treatment (10 weeks)

  6. Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15

    (Baer, Carmody, Hunsinger, 2012; Gu, Strauss, Crane, Barnhofer, Karl, Cavanagh, \& Kuyken, 2016),15-item questionnaire

    Measured: Change from baseline to four months post-treatment (22 weeks)

  7. Non-attachment mindfulness skill as measured by Nonattachment Scale-7

    (Sahdra, Ciarrochi, Parker, Marshall, \& Heaven, 2015) Non-attachment is a specific facet of mindfulness measured by this 7-item questionnaire

    Measured: Change from baseline to immediately post treatment (6 weeks)

  8. Non-attachment mindfulness skill as measured by Nonattachment Scale-7

    (Sahdra, Ciarrochi, Parker, Marshall, \& Heaven, 2015) Non-attachment is a specific facet of mindfulness measured by this 7-item questionnaire

    Measured: Change from baseline to one month post-treatment (10 weeks)

  9. Non-attachment mindfulness skill as measured by Nonattachment Scale-7

    (Sahdra, Ciarrochi, Parker, Marshall, \& Heaven, 2015) Non-attachment is a specific facet of mindfulness measured by this 7-item questionnaire

    Measured: Change from baseline to four months post-treatment (22 weeks)

  10. Relationship satisfaction as measured by Relationship Assessment Scale

    (Hendrick, 1988) 7-item questionnaire

    Measured: Change from baseline to immediately post treatment (6 weeks)

  11. Relationship satisfaction as measured by Relationship Assessment Scale

    (Hendrick, 1988) 7-item questionnaire

    Measured: Change from baseline to one month post-treatment (10 weeks)

  12. Relationship satisfaction as measured by Relationship Assessment Scale

    (Hendrick, 1988)7-item questionnaire

    Measured: Change from baseline to four months post-treatment (22 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2020
  2. Study start14 Apr 2020
  3. Primary completionDec 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Participants will take part in a 6-session MBPST group for treatment of situational ED. Each session will be 2 hours in length and will be spaced one week apart, for a total of 12 hours of treatment time. Participants will also take part in supportive group follow-up sessions at 1- and 4-months following group completion. Treatment endpoints will be assessed at four time-points (pre-treatment, immediate post-treatment, 1-month post-treatment, and 4-months post-treatment).
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04341025
Sponsor's protocol ID
H18-00665
Acronym
PRIMED
Status last verified
Oct 2022
First submitted
27 Jun 2019
Last updated
19 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bossio JA, Basson R, Driscoll M, Correia S, Brotto LA. Mindfulness-Based Group Therapy for Men With Situational Erectile Dysfunction: A Mixed-Methods Feasibility Analysis and Pilot Study. J Sex Med. 2018 Oct;15(10):1478-1490. doi: 10.1016/j.jsxm.2018.08.013.

    PubMed 30297094

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness based psychosexual therapy ( MBPST) in people with Situational Erectile Dysfunction, run by Vancouver Coastal Health at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shauna Correia, MD (604-875-4705, shauna.correia@vch.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5 (time frame: Change from baseline to immediately post treatment (6 weeks)). The study lists 15 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04341025, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in